nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An Atlas of the Hidradenitis Suppurativa Transcriptome
|
Szukala, Weronika |
|
|
14 |
2 |
p. 409-420 |
artikel |
2 |
Applications of Ultraviolet and Sub-ultraviolet Dermatoscopy in Neoplastic and Non-neoplastic Dermatoses: A Systematic Review
|
Pietkiewicz, Paweł |
|
|
14 |
2 |
p. 361-390 |
artikel |
3 |
A Review of the Diagnostic and Therapeutic Gaps in Rosacea Management: Consensus Opinion
|
Del Rosso, James |
|
|
14 |
2 |
p. 271-284 |
artikel |
4 |
Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA)
|
Reich, Kristian |
|
|
14 |
2 |
p. 453-468 |
artikel |
5 |
Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence
|
Bhutani, Tina |
|
|
14 |
2 |
p. 341-360 |
artikel |
6 |
Correction to: Real-Life Utility of Basophil Activation Test in the Diagnosis of Immediate Hypersensitivity Drug Reactions
|
Koumaki, Dimitra |
|
|
14 |
2 |
p. 557-558 |
artikel |
7 |
Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study
|
Schleicher, Stephen |
|
|
14 |
2 |
p. 559-561 |
artikel |
8 |
Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis
|
Saeki, Hidehisa |
|
|
14 |
2 |
p. 533-543 |
artikel |
9 |
Development of a Patient Journey Map for Improving Patient Experience and Quality of Atopic Dermatitis Care
|
Roustán, Gastón |
|
|
14 |
2 |
p. 505-519 |
artikel |
10 |
Does Systemic Anti-Psoriatic Treatment Impact the Risk of Cardiovascular Disease? A Review Over Cardiovascular Imaging Studies
|
Kaiser, Hannah |
|
|
14 |
2 |
p. 303-321 |
artikel |
11 |
Efficacy and Safety of an Autologous Micrografting Procedure for Management of Striae Distensae in Women
|
Girão, Leonor |
|
|
14 |
2 |
p. 469-488 |
artikel |
12 |
Efficacy and Safety of Topical Tacrolimus Microemulsion Applied Twice Daily in Patients with Mild to Moderate Scalp Psoriasis
|
Pinter, Andreas |
|
|
14 |
2 |
p. 521-532 |
artikel |
13 |
Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey
|
Armstrong, April W. |
|
|
14 |
2 |
p. 421-439 |
artikel |
14 |
Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
|
Ludbrook, Valerie J. |
|
|
14 |
2 |
p. 489-504 |
artikel |
15 |
Maintenance of an Acidic Skin Surface with a Novel Zinc Lactobionate Emollient Preparation Improves Skin Barrier Function in Patients with Atopic Dermatitis
|
Andrew, Paul V. |
|
|
14 |
2 |
p. 391-408 |
artikel |
16 |
Podcast on Cross-speciality Perspectives on Practical Management of Atopic Dermatitis-Associated Ocular Surface Diseases
|
Aldredge, Lakshi M. |
|
|
14 |
2 |
p. 293-302 |
artikel |
17 |
Real-World Adverse Events Associated with Encapsulated Benzoyl Peroxide/Tretinoin, 3%/0.1%, and Encapsulated Benzoyl Peroxide, 5%
|
Poteate, Amy |
|
|
14 |
2 |
p. 285-292 |
artikel |
18 |
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor)
|
Gooderham, Melinda |
|
|
14 |
2 |
p. 441-451 |
artikel |
19 |
Successful Treatment of Schwartz-Jampel Syndrome with Botulinum Toxin Type A
|
Suphatsathienkul, Panittra |
|
|
14 |
2 |
p. 545-556 |
artikel |
20 |
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel
|
Burshtein, Joshua |
|
|
14 |
2 |
p. 323-339 |
artikel |